AstraZeneca's shares up 5% as sales driven higher by demand for cancer drugs

Pascal Soriot, the company's chief executive, said the company 'had a very strong start in 2024'

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Derren Nathan ,Hargreaves Lansdown ,Pascal Soriot ,Astrazeneca ,Astrazeneca Plc ,Lung Cancer ,Cancer ,